DAILY UPDATE: Rx MDMA

By Staff Reporters

***

***

A psychedelic drug could be an effective treatment for PTSD, according to research published in Nature Medicine this week.

MDMA, aka “ecstasy” or “molly,” combined with therapy, was shown to produce a “clinically meaningful” improvement for almost 90% of treated patients with moderate and severe PTSD.

MORE: https://nida.nih.gov/publications/research-reports/mdma-ecstasy-abuse/what-mdma

The encouraging results put the currently illicit substance on a path to becoming a prescription drug if US regulators approve it for widespread clinical use.

***
COMMENTS APPRECIATED

Thank You

***

***

***

FTC & DOJ Announce Revised Merger Guideline

By Health Capital Consultants, LLC

***

FTC & DOJ Announce Revised Merger Guidelines

On July 19, 2023, the Federal Trade Commission (FTC) and the Department of Justice (DOJ) released a draft update of its Merger Guidelines, which guides the regulatory agencies in their review of both mergers and acquisitions in evaluating compliance with federal antitrust laws.

The new Guidelines replace, amend, and consolidate the Vertical Merger Guidelines and Horizontal Merger Guidelines, which were published in 2020 and 2010, respectively.

This Health Capital Topics article will discuss the new Guidelines and the proposed changes to antitrust laws that may affect the future of healthcare. (Read more…) 

***

COMMENTS APPRECIATED

Thank You

***

***